Dec 6 (Reuters) - Suda Pharmaceuticals Ltd SUD.AX :
* SUDA PHARMACEUTICALS LTD - ENTERS INTO A FULLY FUNDED FEASIBILITY & OPTION AGREEMENT WITH ZELDA THERAPEUTICS
* SUDA PHARMACEUTICALS LTD - CO TO APPLY PROPRIETARY OROMIST ORO-MUCOSAL SPRAY TECHNOLOGY TO ZELDA'S PHARMACEUTICAL-GRADE CANNABINOID DERIVATIVES